Document is current
Any future updates will be listed below
-
Authors
Doub, James B. https://orcid.org/0000-0002-4977-0968
Wilson, Eleanor
- License Information
-
More Information
Article History
Received: 4 May 2021
Accepted: 27 July 2021
First Online: 30 July 2021
Declarations
:
: None to declare.
: All patients gave informed consent to be administered bacteriophage therapy for their recalcitrant infections and to publish their cases and/or data. All patients included had individual IND’s granted by the FDA through the expanded access pathway. These were individually reviewed and approved by the University of Maryland IRB.
